Solomon Moshkevich - 12 Dec 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
PRESIDENT, CLINICALDIAGNOSTICS
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
12 Dec 2025
Net transactions value
-$868,128
Form type
4
Filing time
16 Dec 2025, 21:05:07 UTC
Previous filing
03 Dec 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN /s/ Vincent Fontanilla, Attorney-in-Fact 16 Dec 2025 0002010019

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Gift $0 -180 -0.17% $0.000000 108,881 12 Dec 2025 Direct F1
transaction NTRA Common Stock Options Exercise $85,121 +8,876 +8.2% $9.59 117,757 12 Dec 2025 Direct
transaction NTRA Common Stock Sale $1,082,714 -4,692 -4% $230.76 113,065 12 Dec 2025 Direct F2
transaction NTRA Common Stock Options Exercise $129,465 +13,500 +12% $9.59 126,565 12 Dec 2025 Direct
transaction NTRA Common Stock Gift $0 -115 -0.09% $0.000000 126,450 15 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -22,376 -81% $0.000000 5,125 10 Dec 2025 Common Stock 22,376 $9.59 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a charitable contribution by the Reporting Person.
F2 The sale of these shares was effected in order to cover the exercise price and satisfy tax withholding and remittance obligations in connection with the exercise of expiring options.
F3 The options exercised were composed of 13,500 incentive stock options and 8,876 non-qualified stock options.
F4 The option shares are fully exercisable.